Brand drug manufacturers use a variety of strategies to extend the exclusivity of their drugs beyond the end of their original 20-year exclusivity period. They use “patent thickets” as an extension tool by filing multiple additional patents on the same drug after it receives FDA approval.
Pharmaceutical Care
Management Association
325 7th Street, NW
Washington, DC 20004
Main: 202.756.5700
©2024 PCMA. All Rights Reserved.